PriceTargets.com logo

Virbac - VRBCF Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$339.23 As of 12/19/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for VRBCF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Virbac Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VRBCF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VRBCF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Virbac in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $339.23.

This chart shows the closing price for VRBCF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Virbac. This rating has held steady since September 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/25/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/23/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/21/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/20/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/18/2022Jefferies Financial GroupDowngradeBuy ➝ Hold€296.00
4/19/2022Oddo BhfUpgradeNeutral ➝ Outperform
7/19/2021Kepler Capital MarketsUpgradeHold ➝ Buy
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.72 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/24/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/23/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Virbac logo
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.
Read More

Today's Range

Now: $339.23
Low: $339.23
High: $339.23

50 Day Range

MA: $374.81
Low: $339.23
High: $382.00

52 Week Range

Now: $339.23
Low: $339.23
High: $383.52

Volume

N/A

Average Volume

100 shs

Market Capitalization

N/A

P/E Ratio

51.29

Dividend Yield

1.15%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Virbac?

The following Wall Street sell-side analysts have issued stock ratings on Virbac in the last twelve months:
View the latest analyst ratings for VRBCF.

What is the current price target for Virbac?

0 Wall Street analysts have set twelve-month price targets for Virbac in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Virbac in the next year.
View the latest price targets for VRBCF.

What is the current consensus analyst rating for Virbac?

Virbac currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for VRBCF.

What other companies compete with Virbac?

Other companies that are similar to Virbac include AstraZeneca, Daiichi Sankyo, Dechra Pharmaceuticals, JCR Pharmaceuticals and Kyowa Kirin. Learn More about companies similar to Virbac.

How do I contact Virbac's investor relations team?

Virbac's physical mailing address is 1ère avenue 2065m LID, Carros, Provence-Alpes-Cote-dAzur 06516. The company's listed phone number is 33.4.92.08.71.00. The official website for Virbac is www.virbac.fr. Learn More about contacing Virbac investor relations.